Desmopressin Acetate NDC 68682-342

NDC codes

FDA NDC Directory

Product NDC (as listed)68682-342Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68682-0342Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68682-342-05	68682034205	1 BOTTLE, PUMP in 1 CARTON (68682-342-05) / 5 mL in 1 BOTTLE, PUMPMarketed from Jun 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desmopressin Acetate
Generic name (nonproprietary): desmopressin acetate
Active ingredients: Desmopressin acetate — .1 mg/mL
Dosage form: Solution
Route: Nasal
Labeler: Oceanside Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074830
Marketing start: Jun 1, 2025
Marketing end: Jan 31, 2028
Other FDA classes: Increased Coagulation Factor VIII Activity (Physiologic effect)Increased Coagulation Factor VIII Concentration (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 68682-342_97c5146c-9da2-408d-859c-c35abbd82893SPL ID 97c5146c-9da2-408d-859c-c35abbd82893SPL set ID 8034989a-45f5-436b-8b1f-42108ee2a21aRxCUI 849506UNII XB13HYU18U
Pharmacologic class: Factor VIII Activator; Vasopressin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468682034205 followed by a unit qualifier and the quantity

Package 68682-0342-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 19, 2025.

Indications (excerpt from the label)

Desmopressin nasal spray solution is indicated as antidiuretic replacement therapy in the management of central diabetes insipidus in adults and pediatric patients 4 years of age and older. Limitations of Use: Desmopressin nasal spray solution is not indicated for: • Treatment of nephrogenic diabetes insipidus, • Treatment of primary nocturnal enuresis [ see Warnings and Precautions (5.1) ], • Use in patients with conditions that compromise the intranasal route of administration (e.g., severe nasal congestion and blockage, nasal mucosa atrophy, severe atrophic rhinitis, recent nasal surgery such as transsphenoidal hypophysectomy) [see Warnings and Precautions (5.2) ], • Use in patients with …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074830

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074830
Product	Strength	Form · route	Labeler	Product NDC
Desmopressin Acetate	Desmopressin acetate .1 mg/mL	SolutionNasal	Bauch & Lomb Incorporated	24208-342